Mallinckrodt Announces 2022 Advancing Extracorporeal Photopheresis Immunomodulation Investigator Award
- Wednesday, November 16, 2022, 7:10
- PR Newswire
- Add a comment
— Winning project hopes to unlock invaluable insights on how ECP could improve quality of life and clinical outcomes in chronic lung allograft dysfunction — DUBLIN, Nov. 16, 2022 /PRNewswire/ — Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today…
About the Author
admin has written 21721 stories on this site.